Association of cytokine levels and reductions in spleen size in COMFORT-II, a phase III study comparing ruxolitinib to best available therapy (BAT).
Claire N Harrison
Consultant or Advisory Role - Celgene; Novartis; S Bio; Sanofi ; YM BioSciences
Stock Ownership - Celgene; Novartis; S Bio; Sanofi ; YM BioSciences
Honoraria - Celgene; Novartis; S Bio; Sanofi ; YM BioSciences
Research Funding - Novartis
Expert Testimony - S Bio
Jean-Jacques Kiladjian
Research Funding - Celgene; Novartis; Shire
Heinz Gisslinger
No relevant relationships to disclose
Francesco Passamonti
Consultant or Advisory Role - Celgene; Novartis; Sanofi
Honoraria - Celgene; Novartis; S Bio; Sanofi ; YM BioSciences
Research Funding - Novartis
Expert Testimony - S Bio
L. Andres Sirulnik
Employment or Leadership Position - Novartis
Ling Wang
Employment or Leadership Position - Novartis
Matthew Squires
Employment or Leadership Position - Novartis
Laurent Knoops
Consultant or Advisory Role - Novartis
Expert Testimony - Novartis
Giovanni Barosi
No relevant relationships to disclose
Tiziano Barbui
No relevant relationships to disclose
Francisco Cervantes
Consultant or Advisory Role - Advisoryt Board